I-MOVE-COVID-19 publications

Protocols

Vaccine effectiveness studies

I-MOVE-COVID-19 hospital network VE generic protocol: European study of COVID-19 vaccine effectiveness against hospitalised SARI patients laboratory-confirmed with SARS-CoV-2

I-MOVE-COVID-19 primary care network VE generic protocol: COVID-19 vaccine effectiveness at primary care level in Europe

Risk factor studies

I-MOVE-COVID-19 hospital network risk factor generic protocol: European study of risk factors for severe disease among hospitalised COVID-19 patients

I-MOVE-COVID-19 primary care network risk factor generic protocol: Risk factors for COVID-19 at primary care level in Europe

Surveillance

I-MOVE-COVID-19 hospital surveillance protocol

I-MOVE-COVID-19 primary care surveillance protocol

Scientific articles

Castilla J., Guevara M., Miqueleiz A., Baigorria F., Ibero-Esparza C., Navascués A., Trobajo-Sanmartín C., Martínez-Baz I., Casado I., Burgui C., Ezpeleta C., The Working Group for the Study of COVID-19 in Navarra. Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study. Journal of Clinical Medicine. 2021; 10(12):2608. https://doi.org/10.3390/jcm10122608

Martínez-Baz I., Miqueleiz A., Casado I., Navascués A., Trobajo-Sanmartín C., Burgui C., Guevara M., Ezpeleta C., Castilla ., Working Group for the Study of COVID-19 in Navarra. Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021. Euro Surveill. 2021;26(21):pii=2100438. https://doi.org/10.2807/1560-7917.ES.2021.26.21.2100438

Fresán U., Guevara M., Elía F., Albéniz E., Burgui C., Castilla J.; Working Group for the Study of COVID-19 in Navarra. (2020), Independent role of morbid obesity as a risk factor for COVID‐19 hospitalization: a Spanish population‐based cohort study. Obesity. Accepted Author Manuscript. doi:10.1002/oby.23029

Martínez-Baz, I., Trobajo-Sanmartín, C., Arregui, I., Navascués, A., Adelantado, M., Indurain, J., Fresán, U., Ezpeleta, C., & Castilla, J. (2020). Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers. Vaccines, 8(4), 611. https://doi.org/10.3390/vaccines8040611

Fresán U., Guevara M., Trobajo-Sanmartin C., Burgui C., Ezpeleta C., Castilla J. (2021), Hypertension and related comorbidities as potential risk factors for COVID‐19 hospitalization and severity: a prospective population‐based cohort study. J Clin Med 2021 10(6); 1194. doi: 10.3390/jcm.10061194.

Kissling E, Hooiveld M, Brytting M, Vilcu AM, de Lange M, Martínez-Baz I, Sigerson D, Enkirch T, Belhillil S, Meijer A, Castilla J, William N, Carnahan A, Falchi A, Hendriksen J, Casado I, Murray J, Enouf V, Dijkstra F, Marques DFP, Valenciano M. Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020. Influenza Other Respir Viruses. 2021 Jan 22:10.1111/irv.12839. doi: 10.1111/irv.12839.